Probably the best
01
Market Access, Health Economics, HTA, & policy – we got you!
02
Do you wish to leverage the great value of Nordic RWE? – We are your partner!
03
We are experts in AI and innovative dashboard solutions that generate real impact!
Curious about the Impact of EU JCA in the Nordics?
Want to hear more about the EU JCA.
How to prepare for the impact of MFN?
Reach out to discuss with our experts!
8
Years
100+
Value & Policy Communications
400+
Access & HEOR Projects
80+
Major Global & EU5 Projects
50+
Nordic RWE Projects
15+
Countries With Extensive Experience
250+
HTA submissions
20+
AI and Dashboard Solutions
The latest
Do you want to gain insight on market trends? Make sure to read the latest news from NHTA.
Our client partners
We Support Major Pharma, Small Biotech, Medtech Companies, Universities, And Public Bodies. Reach Out So We Can Also Support You!
Here Is a Small Selection of Our Clients:
Interactive demos
Built on Nordic RWE · figures shown are illustrative
Our offerings
Market Access Strategy, HTA, and Health Economics
Market Access is Tricky – otherwise you probably wouldn’t be reading this.
Luckily, we know all the ins and outs of Market Access – and we would love to help you!
Nordic RWE & Evidence Generation
It is crucial to utilise the best available evidence and in the best possible way.
How can Nordic RWE be the solution to this?
We can help you answer this – and we have evidence to support this claim.
AI & Dashboard Solutions
Health economists, market access strategists and software engineers in one team.
The people who know how decision makers think help build the tools, so the tools answer the questions that matter and support real decisions.
Policy Shaping & Life Science Consulting
We start with the evidence. We don’t stop there.
We built our name on evidence rigorous enough to win an HTA argument, and we turn that rigour into strategy, decisions and the policy environment around them.
Our work
A roadmap of innovative market access approaches in the Nordics
In preparation to optimise the likelihood of successful launches for selected pipeline assets, a major pharmaceutical company, wished to have a roadmap of innovative ways to gain access and fully understand the competitive landscape in the Nordics.
Building on our vast experience within innovative access approaches, we performed targeted reviews to identify and summarise innovative market access routes in the Nordics. Additionally, to capture information that was not publicly available and to understand future opportunities and trends, we conducted interviews with payers and HTA bodies (e.g. Amgros, TLV) across the Nordics.